➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
AstraZeneca
Harvard Business School
Merck
McKesson

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Daclizumab - Biologic Drug Details


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for daclizumab

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Baylor Health Care SystemPhase 1
Baylor Research InstitutePhase 1
Northwestern UniversityPhase 1

See all daclizumab clinical trials

Recent Litigation for daclizumab

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
PFIZER INC. v. ZYDUS PHARMACEUTICALS (USA) INC.2020-02-27
Pfizer Inc. v. Ajanta Pharma Ltd.2019-03-15
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.2018-12-06

See all daclizumab litigation

PTAB Litigation
PetitionerDate
2017-12-20
2012-09-25

See all daclizumab litigation

Patent Text Search: US Patents for daclizumab

These patents were identified by searching patent claims

Supplementary Protection Certificates for daclizumab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0160040 00210 Estonia ⤷  Try it Free PRODUCT NAME: DAKLIZUMAB;REG NO/DATE: EU/1/16/1107 05.07.2016
2015000061 Germany ⤷  Try it Free PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
01530049 Spain ⤷  Try it Free PRODUCT NAME: TRASTUZUMAB Y HIALURONIDASA HUMANA RECOMBINANTE; NATIONAL AUTHORISATION NUMBER: EU/1/100/145/002; DATE OF AUTHORISATION: 20130826; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/100/145/002; DATE OF FIRST AUTHORISATION IN EEA: 20130826
2016000098 Germany ⤷  Try it Free PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
315 Luxembourg ⤷  Try it Free PRODUCT NAME: PROCEDE DE TRAITEMENT DE LA SCLEROSE MULTIPLE - DACLIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/16/1107
2016 00058 Denmark ⤷  Try it Free PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
20C/505 Belgium ⤷  Try it Free PRODUCT NAME: UPADACITINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/19/1404 20191218
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Dow
Express Scripts
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.